Obstructive coronary artery disease in high-risk diabetic patients with and without atrial fibrillation

Bredy Pierre-Louis1, Wilbert S Aronow, Chandrasekar Palaniswamy

  • 1Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York 10595, USA.

Coronary Artery Disease
|December 25, 2008
PubMed

Insights

Patients with diabetes and atrial fibrillation show more severe coronary artery disease than those with sinus rhythm. This includes a higher prevalence of significant narrowing in major coronary arteries.

Area of Science:

  • Cardiology
  • Diabetology
  • Electrophysiology

Background:

  • Diabetes mellitus and atrial fibrillation are independent risk factors for cardiovascular disease.
  • The combined effect of diabetes and atrial fibrillation on coronary artery disease (CAD) severity requires further investigation.

Purpose of the Study:

  • To compare the severity of coronary artery disease (CAD) in patients with diabetes mellitus and atrial fibrillation versus those with diabetes mellitus and sinus rhythm.

Main Methods:

  • A cohort of 245 patients with diabetes and atrial fibrillation was compared to 245 age- and sex-matched patients with diabetes and sinus rhythm.
  • All patients underwent coronary angiography to assess CAD severity.
  • Baseline characteristics and indications for angiography were similar between groups.

Main Results:

  • A higher prevalence of significant coronary artery narrowing (≥50%) was observed in patients with diabetes and atrial fibrillation (94%) compared to those with diabetes and sinus rhythm (86%) (P<0.01).
  • Specifically, severe three-vessel disease (≥50% narrowing) was more common in the diabetes and atrial fibrillation group (61%) than in the diabetes and sinus rhythm group (31%) (P<0.001).

Conclusions:

  • Patients with diabetes mellitus and concomitant atrial fibrillation exhibit a significantly greater prevalence and severity of coronary artery disease.
  • These findings highlight the increased cardiovascular risk associated with the co-occurrence of diabetes and atrial fibrillation.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...